Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for ...

Boston Scientific (BSX) ended the recent trading session at $104.71, demonstrating a +1.06% swing from the preceding day's closing price. This change lagged the S&P 500's 1.12% gain on the day.

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $115.00. The company’s shares closed ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Needham analyst Michael Matson maintained a Hold rating on Boston Scientific (BSX – Research Report) today. The company’s shares opened today at $104.85. See what stocks are receiving Strong ...

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our Twin Momentum Investor model based on the published ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a strategic investor in SoniVie, Boston Scientific currently holds an equity ...

Shares of BSX opened at $105.41 on Friday. The firm has a market cap of $155.36 billion, a P/E ratio of 84.33, a PEG ratio of 2.79 and a beta of 0.80. Boston Scientific Co. has a twelve month low ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other stocks to invest in from Israel Englander’s portfolio. Millennium Management ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...